C12Y 304/13019
Membrane dipeptidase
Official title: Membrane dipeptidase (3.4.13.19)
C12Y304/13019 (Membrane dipeptidase) appears on 5 US grants and 6 published applications in this corpus.
Search patents in C12Y- Granted patents
- 5
- Published applications
- 6
- Assignees
- 3
- Inventors
- 14
- Latest grant
- 10 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 1 | 3 |
| 2018 | 0 | 0 |
| 2019 | 2 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- DPEP-1 binding compositions and methods of use10 Mar 2026US 12,569,538 B2Arch Biopartners, Inc.
- DPEP-1 binding compositions and methods of use6 Jun 2023US 11,666,631 B2Arch Biopartners, Inc.
- DPEP-1 binding compositions and methods of use3 Dec 2019US 10,493,127 B2Arch Biopartners, Inc.
- Anti-DPEP3 antibodies and methods of use29 Jan 2019US 10,189,910 B2Abbvie Stemcentrx LLC
- Anti-DPEP3 antibodies and methods of use3 Oct 2017US 9,777,071 B2Abbvie Stemcentrx LLC
- DPEP-1 Binding Compositions and Methods of Use4 Apr 2024US 2024/0108686 A1Arch Biopartners, Inc.
- DPEP-1 Binding Compositions and Methods of Use12 Mar 2020US 2020/0078442 A1Arch Biopartners, Inc.
- Dpep-1 binding compositions and methods of use14 Sep 2017US 2017/0258872 A1Arch Biopartners, Inc.
- Novel anti-dpep3 antibodies and methods of use16 Feb 2017US 2017/0044271 A1Abbvie Stemcentrx LLC
- Novel anti-dpep3 antibodies and methods of use2 Feb 2017US 2017/0029530 A1Abbvie Stemcentrx LLC
Most cited
By later US patents